FYFredrik Yannopoulos

Fredrik Yannopoulos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fredrik Yannopoulos has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Vesa Anttila

    A Research Unit of Surgery, Anesthesia and Intensive Care , University of Oulu and Medical Research Center , Oulu , Finland

    12 shared publications
  • Tatu Juvonen

    A Research Unit of Surgery, Anesthesia and Intensive Care , University of Oulu and Medical Research Center , Oulu , Finland

    10 shared publications
  • Tuomas Mäkelä

    A Research Unit of Surgery, Anesthesia and Intensive Care , University of Oulu and Medical Research Center , Oulu , Finland

    8 shared publications
  • Kai Kiviluoma

    Department of Anaesthesiology, Oulu University Hospital, Oulu, Finland

    7 shared publications
  • Petri Lehenkari

    Research Unit of Translational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland

    6 shared publications
  • Henri Haapanen

    Research Unit of Surgery, Anesthesia and Intensive Care, University of Oulu and Medical Research Center, Oulu, Finland

    5 shared publications

Latest Publications

  • Open Access

    Lung cancer resection rate and outcomes during the COVID-19 pandemic in Northern Finland

    by Aapo Pikkujämsä, Tuomas Mäkelä, Olli Helminen, Joonas H. Kauppila, Fredrik Yannopoulos

  • Open Access

    Recommendation-adherent systematic lymph node sampling is not associated with increased complication rates in non-small cell lung cancer surgery—combined cardiothoracic center experience

    by Aapo Pikkujämsä, Tuomas Mäkelä, Joonas H. Kauppila, Olli Helminen, Fredrik Yannopoulos

    Lymph node harvesting during lung resection procedures is a crucial part of treating lung cancer. Despite medical consensus on this issue, the required and safe extent of lymph node harvesting is under debate. A competing, more conservative approach to nodal harvesting suggests that some patients may benefit from limited sampling (LS), thus avoiding complications related to more extensive nodal dissection. Our goal was to evaluate the complication rates with different lymph node sampling strategies. A retrospective single-center cohort study conducted at a combined cardiothoracic unit (n=521) was formed of patients with non-small cell lung cancer (NSCLC) that underwent lobectomy. Patients were divided into three groups based on the extent of mediastinal nodal sampling: no sampling (NS, n=89), LS (n=313) and recommendation-adherent systematic sampling (RA, n=119). Comparison was made between the three groups. The primary outcome was any postoperative complication. Complication rate was similar between the groups, overall complication 38.2% for NS, 39.6% for LS and 35.3% for RA, P=0.30. Comprehensive complication index (CCI) median 0, interquartile range (IQR) 0–20.9 in all groups, P=0.89. The number of severe complications did not differ at a statistically significant level between the groups, NS 12.4%, LS 11.2% vs. RA 17.6%, P=0.20. Main conclusion was that more extensive lymph node harvesting was not associated with increased complication rates in NSCLC patients who underwent lobectomy.

  • Open Access

    Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study

    by Maunu Nissinen, Joonas Lehto, Fausto Biancari, Tuomo Nieminen, Markus Malmberg, Fredrik Yannopoulos, Samuli Salmi, Juhani K. E. Airaksinen, Tuomas Kiviniemi, Juha E. K. Hartikainen

    Background: Preoperative permanent atrial fibrillation (AF) is associated with impaired outcome after surgical aortic valve replacement (SAVR). The impact of preoperative paroxysmal AF, however, has remained elusive.Purpose: We assessed the impact of preoperative paroxysmal AF on outcome in patients undergoing SAVR with bioprosthesis.Methods: A total of 666 patients undergoing isolated AVR with a bioprosthesis were included. Survival data was obtained from the national registry Statistics Finland. Patients were divided into three groups according to the preoperative rhythm: sinus rhythm (n = 502), paroxysmal AF (n = 90), and permanent AF (n = 74).Results: Patients in the sinus rhythm and paroxysmal AF groups did not differ with respect to age (P = .484), gender (P = .402) or CHA2DS2‐VASc score (P = .333). At 12‐month follow‐up, AF was present in 6.2% of sinus rhythm patients and in 42.4% of paroxysmal AF patients (P < .001). During follow‐up, incidence of fatal strokes in the paroxysmal AF group was higher compared to sinus rhythm group (1.9 vs 0.4 per 100 patient‐years, HR 4.4 95% Cl 1.8‐11.0, P = .001). Cardiovascular mortality was higher in the paroxysmal AF group than in the sinus rhythm group (5.0 vs 3.0 per 100 patient‐years, HR 1.70 95% CI 1.05‐2.76, P = .03) and equal to patients in the permanent AF (5.0 per 100 patient‐years).Conclusion: Patients undergoing SAVR with bioprosthesis and history of paroxysmal AF had higher risk of developing permanent AF, cardiovascular mortality and incidence of fatal strokes compared to patients with preoperative sinus rhythm. Life‐long anticoagulation should be considered in patients with a history of preoperative paroxysmal AF.


  • Remote ischaemic preconditioning may prolong permissible period of hypothermic circulatory arrest in a porcine model

    by Caius Mustonen, Hannu-Pekka Honkanen, Tuomas Anttila, Johanna Herajärvi, Fredrik Yannopoulos, Tuomas Mäkelä, Timo Kaakinen, Vesa Anttila, Tatu Juvonen

    Objectives. The hypothermic circulatory arrest (HCA) is still of paramount importance in aortic arch surgery, but the safe period of the arrest is limited. Remote ischaemic preconditioning (RIPC) prepares the cerebral tissue for ischaemic insult. Prolongation of the permissible period of HCA with RIPC may have a major impact on the outcome of aortic operations requiring cessation of blood flow by decreasing the rate of neurological deficits. Design. Twenty pigs were randomised into the RIPC group (n = 10) and the control group (n = 10). The RIPC group underwent four cycles of transient hind limb ischaemia. Both groups underwent cooling with cardiopulmonary bypass to 11 °C followed by a 45-minute HCA and re-warming to 36 °C. Cerebral blood flow was measured with a transit time ultrasonic flowmeter from the right common carotid artery, and the arteriovenous oxygen difference was calculated from sagittal sinus and arterial blood samples. Measurements were taken at several time points during cooling and warming. Temperature coefficient (Q10) was calculated to determine estimated permissible periods of HCA Results. The Q10 was 2.27 (1.98 - 2.58) for the RIPC group and 1.87 (1.61 - 2.25) for the control group. The permissible period of HCA at 18 °C was 26 minutes (20-33) in the RIPC group and 17 minutes (13-25) in the control group (p = 0.063)(Data expressed in medians and interquartile ranges). Conclusions. RIPC tends to suppress cerebral metabolism during cooling with cardiopulmonary bypass and may prolong estimated permissible period of HCA.


  • Performance of CHA2DS2-VASc score for stroke prediction after surgical aortic valve replacement

    by Tuomas Kiviniemi, Joonas Lehto, Maunu Nissinen, Tuomo Nieminen, Juha Hartikainen, Markus Malmberg, Fredrik Yannopoulos, Jyri Savolainen, Pasi Karjalainen, K.E. Juhani Airaksinen, et al.


  • Open Access

    Safety of direct true lumen cannulation after venous exsanguination: a study in a surviving porcine model†

    by Caius Mustonen, Hannu-Pekka Honkanen, Siri Lehtonen, Hannu Tuominen, Tuomas Mäkelä, Timo Kaakinen, Fredrik Yannopoulos, Vesa Anttila, Tatu Juvonen

    Type A aortic dissection requires immediate surgery. Traditional cannulation methods such as the central aortic cannulation with the Seldinger technique and axillary cannulation are primary choices. Yet in the presence of tamponade or severe cardiogenic shock, these can be too time-consuming to complete. Direct true lumen cannulation after venous exsanguination not only avoids this issue but also leads to transient global ischaemia. We studied the safety of direct true lumen cannulation from the aspect of global ischaemia in a surviving porcine model. Twelve pigs were randomized to either control or intervention groups (6 + 6). The intervention group underwent simulated direct true lumen cannulation by exsanguination and circulatory arrest for 5 min at 35°C before cardiopulmonary bypass (CPB). Both groups underwent CPB cooling to 25°C followed by a 25-min arrest period and subsequent warming to 36°C. Neuron-specific enolase levels were measured at 6 time-points from blood samples. Near-infrared spectroscopy was used to determine brain oxygenation. The neurological recovery was evaluated daily during a 7-day follow-up, and the brain was harvested for a histopathological analysis after euthanization. All pigs recovered their normal neurological behaviour. The neurobehavioural total score on postoperative day 2 reached borderline statistical significance, thus favouring the intervention group [(9 (8.75–9) vs 6.5 (5.5–9), P = 0.06]. Near-infrared spectroscopy values and neuron-specific enolase levels slightly favoured the control group during the cooling period, but the difference was not clinically significant. The histopathological analysis showed no difference between the groups. A 5-min period of normothermic global ischaemia before CPB does not impair the neurological outcome following hypothermic circulatory arrest in a surviving porcine model.


  • Open Access

    Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement

    by Tuomas Kiviniemi, Markus Malmberg, Fausto Biancari, Juha Hartikainen, Leo Ihlberg, Fredrik Yannopoulos, Teemu Riekkinen, Otto von Hellens, Joonas Lehto, Maunu Nissinen, et al.

    Post-operative atrial fibrillation (POAF) is a frequent complication after open-heart surgery, and cardioversions (CV) are commonly performed to restore sinus rhythm. However, little data exists on thrombo-embolic risk related to early post-operative CV and on the recurrence of POAF after CV. CAREAVR study sought to assess the rate of strokes, transient ischaemic attacks (TIA), and mortality shortly after POAF-triggered CV in patients who underwent isolated surgical aortic valve replacement (SAVR) with a bioprosthesis. Altogether 721 patients underwent isolated SAVR with a bioprosthesis at four Finnish university hospitals. During post-operative hospitalization, after patients with prior chronic AF were excluded, 309/634 (48.7%) of patients had at least one episode of POAF [median time (interquartile range) 3 (3) days], and an electrical CV was performed in 113/309 (36.6%) of them. The length of hospital stay was not affected by CV. At 30 days follow-up, the rate of stroke, TIA or mortality was higher in those AF patients who underwent CV vs. those who did not (9.7% vs. 3.6%, P = 0.04, respectively; adjusted hazard ratio 2.63, 95% confidence interval 1.00–6.92, P = 0.05). Similar proportion of patients in both groups were in AF rhythm at discharge (32.7% vs. 35.7%, P = 0.18); and at 3 months (25.0% vs. 23.6%, P = 0.40), respectively. In this real-world population of patients undergoing isolated SAVR, the rate of POAF was nearly 50%. One-third of these patients underwent an electrical CV, and they exhibited over two-fold risk for thromboembolisms and mortality. Cardioversion did not affect the short-term prevalence of AF.


  • Open Access

    Two novel direct SPIO labels and in vivo MRI detection of labeled cells after acute myocardial infarct

    by Riikka M Korpi, Kirsi Alestalo, Timo Ruuska, Eveliina Lammentausta, Ronald Borra, Fredrik Yannopoulos, Siri Lehtonen, Jarkko T Korpi, Elisa Lappi-Blanco, Vesa Anttila, et al.

    Background: Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide. Cellular decay due hypoxia requires rapid and validated methods for possible therapeutic cell transplantation. Purpose: To develop direct and rapid superparamagnetic iron oxide (SPIO) cell label for a large-animal model and to assess in vivo cell targeting by magnetic resonance imaging (MRI) in an experimental AMI model. Material and Methods: Bone marrow mononuclear cells (BMMNCs) were labeled with SPIO particles using two novel direct labeling methods (rotating incubation method and electroporation). Labeling, iron incorporation in cells and label distribution, cellular viability, and proliferation were validated in vitro. An AMI porcine model was used to evaluate the direct labeling method (rotating incubation method) by examining targeting of labeled BMMNCs using MRI and histology. Results: Labeling (1 h) did not alter either cellular differentiation potential or viability of cells in vitro. Cellular relaxation values at 9.4 T correlated with label concentration and MRI at 1.5 T showing 89 ± 4% signal reduction compared with non-labeled cells in vitro. In vivo, a high spatial correlation between MRI and histology was observed. The extent of macroscopic pathological myocardial changes (hemorrhage) correlated with altered function detected on MRI. Conclusion: We demonstrated two novel direct SPIO labeling methods and demonstrated the feasibility of clinical MRI for monitoring targeting of the labeled cells in animal models of AMI.


  • Exploring Spinal Cord Protection by Remote Ischemic Preconditioning: An Experimental Study

    by Johanna Herajärvi, Tuomas Anttila, Henna Sarja, Caius Mustonen, Henri Haapanen, Tuomas Mäkelä, Fredrik Yannopoulos, Tuomo Starck, Mika Kallio, Hannu Tuominen, et al.


  • Review of remote ischemic preconditioning: from laboratory studies to clinical trials

    by Vesa Anttila, Henri Haapanen, Fredrik Yannopoulos, Johanna Herajärvi, Tuomas Anttila, Tatu Juvonen

    In remote ischemic preconditioning (RIPC) short periods of non-lethal ischemia followed by reperfusion of tissue or organ prepare remote tissue or organ to resist a subsequent more severe ischemia-reperfusion injury. The signaling mechanism of RIPC can be humoral communication, neuronal stimulation, systemic modification of circulating immune cells, and activation of hypoxia inducible genes. Despite promising evidence from experimental studies, the clinical effects of RIPC have been controversial. Heterogeneity of inclusion and exclusion criteria and confounding factors such as comedication, anesthesia, comorbidities, and other risk factors may have influenced the efficacy of RIPC. Although the cardioprotective pathways of RIPC are more widely studied, there is also evidence of benefits in CNS, kidney and liver protection. Future research should explore the potential of RIPC, not only in cardiac protection, but also in patients with threatening ischemia of the brain, organ transplantation of the heart, liver and kidney and extensive cardiovascular surgery. RIPC is generally well-tolerated, safe, effective, and easily feasible. It has a great prospect for ischemic protection of the heart and other organs.